mindyhausler
@mindyhausler Active 7 months, 2 weeks ago
Rivaroxaban, chemically known as 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxmide, is an odorless, non-hygroscopic, white to yellowish powder, which is only slightly soluble in organic solvents and practically insoluble in water. Rivaroxaban is an orally active direct factor FXa […] View
Base
| Your Name | mindyhausler |
| Your favorite artist(s) | Vincent van Gogh |
mindyhausler’s Friends
Sorry, no members were found.
ARCHIVE
- November 2025 (2)
- October 2025 (1)
- September 2025 (2)
- August 2025 (7)
- July 2025 (10)
- May 2025 (1)
- April 2025 (13)
- March 2025 (2)
- February 2025 (2)
- December 2024 (2)
- November 2024 (12)
- September 2024 (13)
- June 2024 (2)
- May 2024 (7)
- April 2024 (6)
- March 2024 (6)
- February 2024 (19)
- January 2024 (15)
- December 2023 (6)
- November 2023 (11)
- October 2023 (7)
- September 2023 (17)
- August 2023 (20)
- July 2023 (14)
- June 2023 (28)
- May 2023 (23)
- April 2023 (22)
- March 2023 (29)
- February 2023 (29)
- January 2023 (26)
- December 2022 (9)
- November 2022 (21)
- October 2022 (18)
- September 2022 (29)
- August 2022 (28)
- July 2022 (28)
- June 2022 (42)
- May 2022 (38)
- April 2022 (33)
- March 2022 (47)
- February 2022 (43)
- January 2022 (55)
- December 2021 (30)
- November 2021 (36)
- October 2021 (54)
- September 2021 (57)
- August 2021 (55)
- July 2021 (35)
- June 2021 (56)
- May 2021 (45)
- April 2021 (54)
- March 2021 (43)
- February 2021 (41)
- January 2021 (42)
- December 2020 (20)
- November 2020 (52)
- October 2020 (84)
- September 2020 (92)
- August 2020 (66)
- July 2020 (82)
- June 2020 (48)
- May 2020 (66)
- April 2020 (49)
- March 2020 (93)
- February 2020 (80)
- January 2020 (124)
- December 2019 (60)
- November 2019 (55)
- October 2019 (77)
- September 2019 (93)
- August 2019 (106)
- July 2019 (101)
- June 2019 (35)
- May 2019 (68)
- April 2019 (86)
- March 2019 (89)
- February 2019 (99)
- January 2019 (172)
- December 2018 (58)
- November 2018 (84)
- October 2018 (114)
- September 2018 (148)
- August 2018 (153)
- July 2018 (115)
- June 2018 (112)
- May 2018 (112)
- April 2018 (138)
- March 2018 (123)
- February 2018 (198)
- January 2018 (172)
- December 2017 (108)
- November 2017 (119)
- October 2017 (303)
- September 2017 (343)
- August 2017 (283)
- July 2017 (303)
- June 2017 (297)
- May 2017 (322)
- April 2017 (332)
- March 2017 (401)
- February 2017 (406)
- January 2017 (388)
- December 2016 (249)
- November 2016 (389)
- October 2016 (365)
- September 2016 (339)
- August 2016 (377)
- July 2016 (373)
- June 2016 (363)
- May 2016 (298)
- April 2016 (309)
- March 2016 (289)
- February 2016 (206)
- January 2016 (308)
- December 2015 (157)
- November 2015 (178)
- October 2015 (262)
- September 2015 (286)
- August 2015 (247)
- July 2015 (256)
- June 2015 (294)
- May 2015 (233)
- April 2015 (335)
- March 2015 (353)
- February 2015 (320)
- January 2015 (309)
- December 2014 (207)
- November 2014 (250)
- October 2014 (310)
- September 2014 (361)
- August 2014 (349)
- July 2014 (306)
- June 2014 (340)
- May 2014 (354)
- April 2014 (352)
- March 2014 (380)
- February 2014 (326)
- January 2014 (447)
- December 2013 (236)
- November 2013 (312)
- October 2013 (381)
- September 2013 (433)
- August 2013 (321)
- July 2013 (321)
- June 2013 (297)
- May 2013 (304)
- April 2013 (387)
- March 2013 (315)
- February 2013 (217)
- January 2013 (309)
- December 2012 (79)
- November 2012 (116)
- October 2012 (138)
- September 2012 (238)
- August 2012 (308)
- July 2012 (202)
- June 2012 (258)
- May 2012 (184)
- April 2012 (211)
- March 2012 (158)
- February 2012 (178)
- January 2012 (196)
- December 2011 (36)
- November 2011 (7)
- October 2011 (27)
- September 2011 (38)
- August 2011 (43)
